4//SEC Filing
Gaston-Dreyfus Remi 4
Accession 0001144204-19-018387
CIK 0001508381other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 3:40 PM ET
Size
5.5 KB
Accession
0001144204-19-018387
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2019-03-28$3.89/sh+197,234$766,747→ 1,095,054 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA)
Footnotes (2)
- [F1]Effective as of March 28, 2019, an aggregate amount of $766,750 of principal and accrued interest in convertible promissory notes issued to RGD Investissements (the "Notes") converted in accordance with their terms into 197,234 shares of the Issuer's common stock.
- [F2]The conversion price of the Notes was calculated using the VWAP (as defined in the Notes) average of the last 30 days before March 28, 2019.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001716639
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 3:40 PM ET
- Size
- 5.5 KB